glp 1 for cardiovascular disease JCI Potential Mechanisms for Pro-Vascular Benefit

9-11 This review should be concluded with the acknowledgement of an important limitationthese trials had a relatively short duration

Most protocols follow a pattern like: Start at a low dose Increase every few weeks if you are tolerating it well Adjust pace based on side effects and progress Some people feel appetite changes within the first 12 weeks, but meaningful weight change typically builds over time

Type 2 diabetes and insulin: dont be scared, heres what you need to know : Think you might be ready for insulin

While LBM loss was evident, it was relatively modest compared to body mass loss

The frequently reported absence of peripherally administered GLP-1 mimetics to regulate energy expenditure in mice and humans has several implications

This expansion in use aligns with the growing recognition of obesity as a medical condition that demands effective treatment strategies